SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Sci Rep. 2018;8(1):13155.

Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline.

, , , , , , , , , ,

제1저자 이지현 · 교신저자 강시혁

소속 (6)
  1. Department of Cardiology, Wonju Medical College, Yonsei University, Wonju, Korea.
  2. Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam-si, Korea.
  3. Department of Internal Medicine, Seoul National University, Seoul, Korea.
  4. Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam-si, Korea. eandp303@snu.ac.kr.
  5. Department of Internal Medicine, Seoul National University, Seoul, Korea. eandp303@snu.ac.kr.
  6. Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.

Abstract

The 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guideline lowered the threshold defining hypertension and treatment target from 140/90 mmHg to 130/80 mmHg. We compared the 2017 ACC/AHA guideline and the Eighth Joint National Committee (JNC8) report with regard to the current status of hypertension using the Korean National Health and Nutrition Examination Survey. The association between blood pressure (BP) control and long-term major cardiovascular outcomes (MACEs) was analyzed using the Korea National Health Insurance Service cohort. In the cross-sectional study with 15,784 adults, the prevalence of hypertension was expected to be 49.2 ± 0.6% based on the definition suggested by the 2017 ACC/AHA guideline versus 30.4 ± 0.6% based on the JNC8 report. In a longitudinal analysis with 373,800 hypertensive adults for the median follow-up periods of 11.0 years, the adults meeting the target goal BP goal of 2017 ACC/AHA guideline were associated with 21% reduced risk of MACEs compared with adults, not meeting 2017 ACC/AHA BP goal but meeting JNC8 target goal. In conclusion, substantial increase of prevalence of hypertension is expected by the 2017 ACC/AHA guideline. This study also suggests endorsing the aggressive approach would lead to an improvement in cardiovascular care.

Figures

Figure 1
Figure 1 The potential impact of implementing the 2017 ACC/AHA guideline for high blood pressure (BP) based on hypertension prevalence (left panel) and hypertension control (right panel). The 2017 ACC/AHA: 2017 American College of Cardiology/American Heart Association Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults; JNC8: Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee.
Figure 2
Figure 2 Restricted cubic spline curve of achieved blood pressure and adjusted risk of cardiovascular events: (left) systolic blood pressure, and (right) diastolic blood pressure. Curves represent adjusted hazard ratios (solid line) and the 95% confidence intervals (shades). The distributions of achieved systolic and diastolic blood pressure are also shown (bars).
Figure 3
Figure 3 Kaplan-Meier survival curve free from major cardiovascular events among hypertensive subjects according to their achieved blood pressure. The red line indicates subjects who achieved the target blood pressure recommended by the 2017 ACC/AHA guidelines (2017 ACC/AHA group); the blue line indicates subjects who achieved the target blood pressure recommended by the JNC8 guidelines but not the 2017 ACC/AHA guidelines (JNC8 group); the purple line indicates subjects who achieved neither target goal (poor group).

그림 출처: PubMed Central 공개 논문 (PMC6120944)

Conflict of interest statement

The authors declare no competing interests.

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
Scientific reports · eISSN 2045-2322
전자 출판
2018-09-03
MeSH
Aged · Antihypertensive Agents / therapeutic use · Blood Pressure / drug effects · Blood Pressure Monitoring, Ambulatory / methods · Cross-Sectional Studies · Female · Health Surveys · Humans · Hypertension / drug therapy / epidemiology / mortality / physiopathology · Male · Middle Aged · Practice Guidelines as Topic · Prevalence · Republic of Korea / epidemiology · Survival Analysis · Treatment Outcome
Substances
Antihypertensive Agents
참고문헌
30편